Article (Scientific journals)
Pazopanib (Votrient) dans le traitement du cancer du rein et des sarcomes des tissus mous.
GENNIGENS, Christine; JERUSALEM, Guy
2012In Revue Médicale de Liège, 67 (7-8), p. 437-42
Peer reviewed
 

Files


Full Text
Pazopanib (Votrient) dans le traitement du rein et des sarcomes des tissus mous.pdf
Publisher postprint (153.04 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Antineoplastic Agents/pharmacology/therapeutic use; Carcinoma, Renal Cell/drug therapy; Humans; Kidney Neoplasms/drug therapy; Protein-Tyrosine Kinases/antagonists & inhibitors; Pyrimidines/pharmacology/therapeutic use; Sarcoma/drug therapy; Soft Tissue Neoplasms/drug therapy; Sulfonamides/pharmacology/therapeutic use; oncology
Abstract :
[en] Renal cell carcinoma accounts for 3% of all malignant tumors. Until a few years ago, immunotherapy (Interferon and/or Interleukin-2) was the only approved systemic treatment in the metastatic setting. Better knowledge of renal cell cancer biology drew attention on the fundamental role of angiogenesis. Several strategies targeting angiogenesis have been developed including VEGF and VEGFR inhibitors. They are now the standard treatment in first and second line. Pazopanib, a VEGFR tyrosine kinase inhibitor, is one of the treatment options recommended for patients with metastatic renal cell carcinoma, in first line and after cytokines failure. Since more recently, pazopanib is also approved in the treatment of metastatic soft tissue sarcoma, after failure of at least one line of chemoterapy. In this paper, we will review the mechanism of action and the clinical results of pazopanib in renal cell carcinoma and sarcoma.
Disciplines :
Oncology
Author, co-author :
GENNIGENS, Christine  ;  Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
JERUSALEM, Guy  ;  Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Language :
French
Title :
Pazopanib (Votrient) dans le traitement du cancer du rein et des sarcomes des tissus mous.
Alternative titles :
[en] Pazopanib (Votrient) in the management of renal cell cancer and soft tissue sarcomas
Publication date :
2012
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Volume :
67
Issue :
7-8
Pages :
437-42
Peer reviewed :
Peer reviewed
Available on ORBi :
since 21 February 2013

Statistics


Number of views
188 (4 by ULiège)
Number of downloads
2339 (8 by ULiège)

Scopus citations®
 
3
Scopus citations®
without self-citations
3

Bibliography


Similar publications



Contact ORBi